Browsing by Author Gascón, Pere

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 29 to 33 of 33 < previous 
Issue DateTitleAuthor(s)
12-May-2016The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 PseudokinaseErazo, Tatiana; Lorente, Mar; López Plana, Anna; Muñoz Guardiola, Pau; Fernandez-Nogueira, Patricia; García-Martinez, José A.; Bragado, Paloma; Fuster Orellana, Gemma; Salazar, María; Espadaler, Jordi; Hernández Losa, Javier; Bayascas, Jose R.; Cortal, Marc; Vidal, Laura; Gascón, Pere; Gómez Ferreria, Mariana; Alfón, José; Velasco, Guillermo; Domènech, Carles; Lizcano, José Miguel
6-Mar-2009The Role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatinAlmendro Navarro, Vanessa; Ametller, Elisabet; Garcia Recio, Susana; Collazo, Olga; Casas, Ignasi; Augé Fradera, Josep Maria; Maurel Santasusana, Joan; Gascón, Pere
26-Jun-2015The transmodulation of HER2 and EGFR by Substance P in breast cancer cells requires c-Src and metalloproteinase activation.Garcia Recio, Susana; Pastor Arroyo, Eva M.; Marín Aguilera, Mercedes; Almendro Navarro, Vanessa; Gascón, Pere
2010Tumor promoting effects of CD95 signalling in chemoresistant cellsAmetller, Elisabet; Garcia-Recio, Susana; Costamagna, Domiziana; Mayordomo, Cristina; Fernandez-Nogueira, Patricia; Carbó Carbó, Neus; Pastor Arroyo, Eva M.; Gascón, Pere; Almendro Navarro, Vanessa
8-Dec-2020Unraveling the role of fibroblasts, FGF5 and FGFR2 in HER2-targeted therapies resistance and tumor progressionBragado, Paloma; Fernández-Nogueira, Patricia; Carbó Carbó, Neus; Gascón, Pere